Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life
- 23 December 2014
- journal article
- Published by Wiley in Clinical Genetics
- Vol. 88 (5) , 425-430
Abstract
Neurofibromatosis type 1 (NF1) carries a significant psychosocial burden for affected individuals. The objective of this study was to measure the prevalence of depressive symptoms among a large sample of adults with NF1 and to quantify the impact of depressive symptoms on quality of life (QoL). This cross‐sectional study used an Internet‐based questionnaire to collect data from 498 adults who self‐reported as having NF1. Using the Center for Epidemiologic Studies Depression (CESD) scale, 55% of all participants (61% of females and 43% of males) scored above 16, indicating a high likelihood of clinical depression. In a multivariate regression model controlling for demographics and potential confounders, depressive symptoms accounted for 32% of the variance in QoL as measured by the Quality of Life Index. This study is the largest to date and found the highest prevalence of depression compared to prior studies. Our data provide more compelling evidence that individuals with NF1 are at increased risk for psychiatric morbidity and suggest that this population should be routinely screened for depression. Because depression was found to be strongly associated with QoL and accounted for nearly one‐third of the variance in QoL, it is likely that effectively treating depression may significantly enhance QoL for individuals with NF1.Keywords
Funding Information
- National Human Genome Research Institute (MOP-115056)
This publication has 26 references indexed in Scilit:
- Physical, Cognitive, and Psychosocial Predictors of Functional Disability and Health-Related Quality of Life in Adolescents with Neurofibromatosis-1Pain Research and Treatment, 2012
- Quality of life in rare genetic conditions: A systematic review of the literatureAmerican Journal of Medical Genetics Part A, 2010
- Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 casesBritish Journal of Dermatology, 2009
- Health-Related Quality of Life in Children with Neurofibromatosis Type 1: Contribution of Demographic Factors, Disease-Related Factors, and BehaviorThe Journal of Pediatrics, 2009
- Health-Related Quality of Life in Patients with Neurofibromatosis Type 1Dermatology, 2008
- Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1The Journal of Pediatrics, 2006
- Guidelines for the diagnosis and management of individuals with neurofibromatosis 1Journal of Medical Genetics, 2006
- Perception of disease severity in adolescents diagnosed with neurofibromatosis type 1Journal of Adolescent Health, 2004
- Living with achondroplasia in an average‐sized world: An assessment of quality of lifeAmerican Journal of Medical Genetics Part A, 2003
- The CES-D ScaleApplied Psychological Measurement, 1977